Cargando…
Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis
BACKGROUND: The optimal drug for treatment with polycystic ovary syndrome (PCOS) was in debate. We did this network meta-analysis to assess the efficacy and safety of different drugs for reducing testosterone levels in women with PCOS. METHODS: We searched studies from inception until January 10, 20...
Autores principales: | Hao, Song-Li, Zhang, Chun-Lan, Meng, Xiao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578672/ https://www.ncbi.nlm.nih.gov/pubmed/37832133 http://dx.doi.org/10.1097/MD.0000000000035152 |
Ejemplares similares
-
Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022) -
Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Yang, Yijiao, et al.
Publicado: (2021) -
Metformin and acupuncture for polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Gao, Yang, et al.
Publicado: (2020) -
Effects of vitamin D supplementation on serum lipid profile in women with polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Shi, Xiao-yan, et al.
Publicado: (2020) -
The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients
por: Luo, Yunyao, et al.
Publicado: (2020)